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SUMMARY. Dendritic cells (DCs) in chronic hepatitis C
patients display impaired function, although the details
remain unclear. To investigate the hepatitis C virus (HCV)
protein that has the most impact on DC function, we com-
pared ﬁve recombinant proteins and seven HCV protein
genes in modulating DC phenotype and function. Immature
DCs (iDCs) were established from healthy donor peripheral
blood monocytes with granulocyte–macrophage colony
stimulating factor (GM-CSF) and IL-4. Lipopolysaccharide
was used to establish mature DCs (mDCs). Cells were then
pulsed with HCV recombinant proteins or transfected with
HCV plasmids and subsequently assayed for cell surface
marker expression by ﬂow cytometry. For cytokine and
proliferative T-cell response analysis, DCs were cultured with
autologous CD4 T cells and tuberculin puriﬁed protein
derivative (PPD). Mean ﬂuorescent intensity of CD86 was
reduced in HCV protein-pulsed iDCs. Proliferative T-cell
responses and Th1 cytokine concentrations were reduced
with HCV nonstructural proteins (NS), particularly with
HCV NS4. HCV nonstructural proteins, particularly NS4,
change the iDC phenotype and reduce antigen-speciﬁc T-cell
stimulatory function with Th1 cytokine reductions.
Keywords: dendritic cell, hepatitis C virus, T cell.
INTRODUCTION
Hepatitis C virus (HCV) is a major causative agent of chronic
hepatitis. About 70% of infected patients develop chronic
hepatitis, subsequently resulting in liver cirrhosis and
hepatocellular carcinoma [1]. Because HCV is not a cyto-
pathic virus, immune reactions play a central role in the
development of chronic hepatitis [2]. The lack of a strong
Th1-type helper T-cell response and cytotoxic T-cell response
against HCV leads to chronic infection with this virus [3–5].
Strong T-cell responses correlate with spontaneous recovery
[3,6,7], but these responses are not correlated with inter-
feron-induced sustained virological response (SVR) [8]. To
identify mechanisms for these T-cell immune response
defects in chronic hepatitis C, dendritic cells (DCs) function
has been investigated in recent years.
DCs are thought to play a central role in the interplay
between innate and adoptive immune responses. Recently,
two subsets of DCs have been characterized. While myeloid
DCs (mDCs) produce large amounts of IL-12 upon stimula-
tion, plasmacytoid DCs (pDCs) produce large amounts of
interferon-alpha (IFNa) in viral infection [9].
DC function has been reported as broadly impaired in
chronic hepatitis C patients [10–13]. However, several
reports have produced contradictory results that DC function
is not impaired in chronic hepatitis C patients [14–18]. Most
of these reports are studies employing mDCs. However, pDCs
are also reportedly functionally impaired and reduced in
number by increased apoptosis [19]. Because culture con-
ditions and chronic hepatitis conditions in the patient may
change the phenotype of immune cells, functional
differences in DCs during chronic HCV infection remain
contentious. In vitro transfection or addition of HCV proteins
such as core or NS3 has been reported to result in reduced
function of DCs. Because of constrains in maintaining long
term in vitro culture systems for HCV, these experimental
results are also contentious. Recently, Shiina et al. [9] have
shown that using an infectious cell-culture produced HCV
impaired pDC function that could be more likely the in vivo
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recombinant proteins suggested.
HCV possesses a single-strand, positive-sense RNA genome
of approximately 9.6 kb encoding a single polyprotein [20].
This precursor protein is cleaved into at least 10 proteins.
These proteins reportedly display many functions that are
related to the host immune system. The core protein report-
edly inhibits differentiation and allo- and auto-stimulatory
functions of DCs and may induce interleukin (IL)-10 over-
production [13]. The NS3 protein binds directly to interferon
regulatory factor (IRF) 3 to downregulate its function [21].
The NS4 protein slows the rate of endoplasmic reticulum
(ER)-to-Golgi trafﬁc, interfering with maturation of the HLA
complex [22]. NS5a downregulates host interferon responses
against viral infection [23]. As a result, almost all HCV com-
ponent proteins exhibit functionality in interfering with host
immune pressure. However, which protein exerts the most
effect on escaping from immune pressure remains unclear.
The present study examined the effect of individual HCV
proteins (core, NS2, NS3, NS4 and NS5) on DCs function
from healthy volunteers in relation to auto-stimulation of
CD4 T cells. We found that HCV NS4 had the most effect in
downregulating Th1-type helper T-cell responses in com-
parison with other HCV proteins.
MATERIALS AND METHODS
Samples
Subjects comprised of 8 healthy male volunteers (serologi-
cally negative for HCV, hepatitis B virus and human
immunodeﬁciency virus, mean age, 33 ± 5 years). All study
protocols were approved by the Committee for Human
Subjects in Research at Okayama University, and informed
consent was obtained from all participants.
HCV recombinant proteins and HCV-containing plasmids
HCV recombinant proteins including core, NS3, NS4, NS5A
and NS5B were purchased from Mikrogen GmbH (Martins-
ried, Germany), respectively. Mammalian expression
plasmids pCXN2-core, -NS2, -NS3, -NS4A, -NS4B, -NS5A
and -NS5B, which contained the respective HCV genomic
regions and are driven by a b-actin-based CAG promoter
[24], were kindly donated by Dr Naoya Kato from the
Department of Gastroenterology at Tokyo University.
CD14-positive monocyte isolation and myeloid DC
generation
Mononuclear cells were separated from peripheral blood by
centrifugation on Ficoll–Hypaque density gradient (Amer-
sham Pharmacia, Uppsala, Sweden), as previously described.
CD14-positive monocytes were puriﬁed positively using
microbeads (Miltenyi Biotec, Auburn, CA, USA) in accor-
dance with the protocols of the manufacturer. In brief,
peripheral blood mononuclear cells (PBMCs) were incubated
with CD14 microbeads, and then CD14-positive cells were
positively sorted using a magnetic-activated cell-sorting
system (MACS; Miltenyi Biotec). The positively selected
fraction proved to be >95% positive for CD14 by ﬂow cyto-
metric analysis staining with FITC-conjugated anti-CD14
antibody (BD Pharmingen, San Jose, CA). CD14-positive cells
were cultured at 1 · 10
6 mL)1 in RPMI supplemented with
5% heat-inactivated human AB serum (ICN Biomedicals;
Aurora, OH, USA), 100 ng mL)1 of granulocyte–macro-
phage colony stimulating factor (GM-CSF) (kindly provided
by Kirin Pharma, Tokyo, Japan) and 50 ng mL)1 of IL-4
(kindly provided by Ono Pharmaceuticals, Osaka, Japan) at
37  Ci n5 %C O 2 for 5 days. Cells proved to be CD11c-
positive myeloid immature DCs (iDCs).
Cultures were pulsed with 1 lgm L )1 of each HCV pro-
tein. For transfection experiments, DCs were transfected with
HCV plasmids by lipofection using Effectene transfection
reagent (Qiagen, San Jose, CA, USA) according to the
manufacturers protocols. HCV protein-pulsed and HCV-
transfected DCs were cultured for an additional 1 day and
then used in the following experiment. For maturation using
mature DCs (mDCs), 1 ng mL)1 of lipopolysaccharide (LPS)
(Sigma, St Louis, MO, USA) was added to the culture 1 day
after HCV protein addition or HCV plasmid transfection.
DC surface marker analysis by ﬂow cytometry
DCs were stained with FITC-conjugated monoclonal anti-
bodies (anti-human CD11c, CD40, CD86, HLA-ABC,
HLA-DR and relevant isotype controls; BD Pharmingen, San
Diego, CA). Cells (1 · 10
5) were incubated with each anti-
body for 20 min at 4  C in the dark and washed twice with
1% FCS PBS. Cells were analysed using FACScan (BD
Immunocytometry Systems, San Diego, CA, USA). Expres-
sion of each surface marker was analysed by CellQuest (BD
Immunocytometry Systems). Mean ﬂuorescent intensity
(MFI) of each surface marker was calculated, and results
were expressed as MFI index (MFI of the target protein/MFI
of buffer control or control plasmid).
Quantiﬁcation of CD4 T-cell stimulatory function
HCV recombinant protein-pulsed DCs or HCV plasmid-
transfected DCs were tested for antigen-speciﬁc autologous-
CD4 T-cell stimulatory function. DCs (3 · 10
3 per well) were
cultured with auto-CD4 T cells (2 · 10
5 per well) as
responder cells and with tuberculin puriﬁed protein deriva-
tive (PPD) (Japan BCG Laboratory, Tokyo, Japan) as a recall
antigen in 96-well round bottom plates (#3799; Corning,
NY) at a concentration of 0.1 lgm L )1. Next, [methyl-
3H]-
thymidine (TRK637; GE Healthcare Amersham Biosciences,
Buckinghamshire, UK) was added on day 5, and thymidine
incorporation was measured after 16 h. Results were
  2009 Blackwell Publishing Ltd
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protein/cpm of buffer control or control plasmid).
Cytokine analysis
Supernatants of recombinant protein-pulsed or plasmid-
transfected DCs cocultured with CD4 T cells (2 · 10
5 well-
1), and PPD (0.1 lgm L )1) were collected on day 2 and
stored at )80  C. Supernatants were thawed just before use
and analysed for interferon (IFN)-c, IL-2, IL-4 and IL-6
production using a particle-based immunoassay that detects
ampliﬁed ﬂuorescence by ﬂow cytometry (BD Cytometric
Bead Array Human Th1 Th2-1 Cytokine Kit-II; BD Bio-
sciences Pharmingen, San Diego, CA, USA). Results were
recorded as relative concentration index (pg mL)1 of target
protein/pg mL)1 of buffer control or control plasmid).
Statistical analysis
Resultswereexpressedasrelativeindicescomparedtocontrol.
To compare the mean values of relative indices, the Kruskal–
Wallis test with the Dunnett post-test or Students t-test was
used with JMP software (SAS Institute, Cary, NC, USA).
RESULTS
Effect of recombinant HCV protein addition on surface
marker expression of DCs
Mean ratios of surface markers on DCs following addition of
HCV recombinant proteins for the eight donors are shown
in Fig. 1. The expression of CD86 was reduced in DCs
exposed to NS4 compared with NS3 or NS5B (Fig. 1a).
However, this difference was overcome with maturation of
DCs (Fig. 1b).
Effect of HCV protein encoding plasmid transduction on
DC surface marker expression
MFI ratios of surface markers on DCs following transduction
with HCV protein encoding plasmids are shown in Fig. 2.
CD86 expression once again was relatively reduced with
HCV NS4A (Fig. 2a), although this did not reach statistical
signiﬁcance.
However, maturation of these iDCs with LPS overcame the
reduced CD86 expression induced by HCV-plasmid trans-
fection (Fig. 2b).
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Fig. 1 MFI of HLA and co-stimulatory molecules on dendritic cells (DCs) was reduced with hepatitis C virus (HCV) protein
addition. HCV protein-pulsed DCs are shown as p-core, p-NS3, p-NS4, p-NS5A, p-NS5B. (a) MFI index of HLA class I and II
and co-stimulatory molecules CD40 and CD86 expressed on HCV protein-pulsed DCs. CD86 was reduced by addition of HCV
NS4 protein compared with HCV NS3 and NS5B. (b) MFI of surface markers of DCs pulsed with HCV recombinant proteins
after maturation with LPS. HCV protein-pulsed DCs showed comparable ability to mature in terms of surface expression of
co-stimulatory molecule. *P < 0.05 (Students t-test).
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on PPD-speciﬁc CD4 T-cell stimulatory function of DCs
To investigate the effect of HCV on antigen-speciﬁc immune
responses, a recall antigen PPD was used as a stimulant for
DC and auto-CD4 T-cell co-culture experiments. HCV
protein-pulsed DCs showed no difference in T-cell stimula-
tory responses (Fig. 3). HCV plasmid transfection on the
other hand showed low stimulatory responses with NS4B
compared with NS4A (Fig. 4a).
Maturation of DCs with LPS overcame the impaired PPD-
speciﬁc CD4 T-cell stimulatory function of DCs (Fig. 4b).
Regulatory effect of recombinant HCV proteins on Th1
cytokine production in PPD, CD4 T cell and DC co-culture
system
Supernatant from CD4 T cells and DC co-cultures was col-
lected and analysed for Th1 and Th2 cytokine production.
IFNc and IL-2, as representative Th1 cytokines, were
decreased with addition of NS4 (Fig. 5a). Conversely, IL-4
and IL-6, as representative Th2 cytokines, were unaffected
by HCV protein addition.
Maturation of DCs with LPS once again overcame the
impaired PPD-speciﬁc CD4 T-cell stimulatory function of DCs
(Fig. 5b).
The same experiment was performed with plasmids
encoding HCV proteins following transfection of DCs. Pro-
duction of Th1 and Th2 cytokines was unaffected by HCV
plasmid transduction (Fig. 6).
DISCUSSION
Our results demonstrate that HCV recombinant protein
pulsing or HCV plasmid transfection of myeloid DCs reduces
expression of co-stimulatory molecules and reduces Th1
immune responses. However, maturation of DCs overcame
HCV-induced deterioration of the myeloid DC phenotype and
restored function.
DCs are the most potent antigen-presenting cells that can
activate naı ¨ve CD4 T cells. While isolating a sufﬁcient
number of native circulating DCs from PBMCs for functional
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Fig. 2 MFI of HLA class I and II and co-stimulatory molecules CD40 and CD86 expressed on dendritic cells (DCs) transfected
with hepatitis C virus (HCV) protein encoding plasmids. HCV protein encoding plasmids are shown as g-core, g-NS2, g-NS3,
g-NS4A, g-NS4B, g-NS5A, g-NS5B. (a) HCV protein encoding plasmid-transduced DCs showed comparable ability to mature
in relation to surface expression of co-stimulatory molecules. (b) MFI of surface markers on DCs matured with LPS following
transfection with HCV protein encoding plasmids. These DCs showed comparable ability to mature in terms of surface
expression of co-stimulatory molecules.
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558 A. Takaki et al.analysis is difﬁcult, myeloid DCs differentiated from periph-
eral blood monocytes can be used by culturing with GM-CSF
and IL-4. In patients with chronic hepatitis C, some studies
have proposed a defect in myeloid DC function [10–13],
while others have found no such defect [14–18]. These data
were derived using immunological assays of peripheral blood
lymphocytes from chronic hepatitis C patients. These assay
results could be inﬂuenced by the grade and stage of chronic
hepatitis or co-existing clinically negligible diseases such as
atopic dermatitis, allergic pharyngitis and the common cold,
all of which may change the function of immune cells.
Serum autoantibodies are more common in chronic hepatitis
C patients with severe biochemical activities and histological
grading [25] and are also signiﬁcantly associated with cir-
rhosis and older age [26]. Hypergammaglobulinemia is an-
other typical ﬁnding in liver cirrhosis patients. In such
conditions showing autoimmune phenomena, B cells and
related immune cells such as DCs and helper T cells should
be more activated and more Th2-polarized than in patients
without autoimmune phenomena.
The most frequently used immunological assay in pre-
vious studies was allo-stimulatory function analysis using
allogenic mixed lymphocyte reactions (MLR) [10,11,13–
17]. The MLR is a mixed culture response with DCs of
chronic hepatitis C patients and T cells of healthy donors.
This response depends on the degree of HLA class II
matching between donors [27]. Because HLA class II
haplotype reportedly inﬂuences outcome in chronic hepa-
titis C patients [28–30], HLA class II distribution may differ
between chronic hepatitis C patients and healthy donors. In
such a case, MLR responses would be inﬂuenced by
different HLA class II distributions in chronic hepatitis C
patients.
To overcome the problems associated with allo-MLR
assays using patient lymphocytes and to evaluate the inﬂu-
ence of HCV on DC function, we compared the phenotype
and autologous CD4 T-cell stimulating function of myeloid
iDCs established from healthy donor peripheral blood with
HCV recombinant protein pulses and HCV protein encoding
plasmids following transfection. As a recall antigen, we used
PPD to stimulate DCs and autologous CD4 T cells in a mix
culture that is unaffected by HLA class II distribution in the
study population. In Japan, the Bacille Calmette Guerin
(BCG) vaccination has been enforced since 1951, because of
the nationwide tuberculosis endemic after World War II
[31]. PPD is thus a good candidate for a recall antigen to
detect antigen-speciﬁc immune responses in the Japanese
population.
In the present study, functional experiments were all
planned using healthy donor autologous-lymphocytes that
should not be affected by HLA matching. HCV recombinant
proteins and HCV plasmids, particularly NS4, reduced
auto-stimulatory functions. Antigen-speciﬁc CD4 T-cell
stimulatory function of DCs was evaluated using this
autologous CD4 T cell and DC co-culture with PPD.
Recombinant HCV protein addition revealed that NS4
protein showed the strongest reduction in CD86 expression
on iDCs and Th1 cytokine production. The transduction
experiment also showed that NS4 protein relatively impaired
the antigen-presenting function.
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Fig. 3 CD4 T-cell proliferation with
tuberculin puriﬁed protein derivative
(PPD) and dendritic cells (DCs) was not
affected by recombinant hepatitis C
virus (HCV) protein addition. (a) CD4
T-cell proliferation with PPD and DCs
after addition of HCV core, NS3, NS4,
NS5A and NS5B recombinant proteins.
No difference was observed in
PPD-speciﬁc T-cell proliferative
responses with HCV recombinant
protein addition. (b) DCs pulsed with
HCV recombinant proteins and sub-
sequent maturation with LPS. As in the
case of iDCs, no difference was observed
in PPD-speciﬁc T-cell proliferative
responses with HCV recombinant
protein addition.
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Fig. 4 Effect on CD4 T-cell prolifera-
tion with tuberculin puriﬁed protein
derivative (PPD) following transfection
with hepatitis C virus (HCV) protein
encoding plasmids. (a) CD4 T-cell
proliferation with PPD and iDCs was
relatively reduced by exposure to NS4B
compared with NS4A. (b) Dendritic cells
(DCs) transduced with HCV plasmids
and subsequently matured with LPS.
Relative reduction in CD4 T-cell
stimulatory function by NS4B was
overcome by LPS maturation.
*P < 0.05 (Students t-test).
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Fig. 5 Recombinant NS4 protein addition reduced production of Th1 cytokines in antigen-speciﬁc CD4 T-cell responses. (a)
Cytokine proﬁle of supernatant from mixed culture of CD4 T cells, PPD and dendritic cells (DCs) after pulsing with hepatitis C
virus (HCV) recombinant proteins. NS4 addition reduced production of Th1 cytokines IFNc and IL-2, whilst Th2 cytokines IL4
and IL6 were unaffected. (b) Maturation of DCs with LPS rescued Th1 cytokine production after pulsing with HCV
recombinant proteins. No effect was seen with HCV protein encoding plasmids. *P < 0.05 (Dunnett post-test).
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(HIV) show clinical immune defects and also in vitro
functional defects of immune cells such as DCs in addition
to CD4 T cells that are infected with the virus [32,33].
Although HCV-infected patients might show reduced
function of DCs, they are not clinically immunosuppressed
even after several decades of infection. Our results indicate
that HCV proteins cause a relative reduction in surface
expression of the important co-stimulatory molecule CD86
on iDCs, but LPS maturation can rescue this effect. This
may explain the clinical observation that HCV-infected
individuals are not overtly immunosuppressed as HIV-
infected patients.
NS4 protein is a required cofactor for NS3 protease
activity. Co-immunoprecipitation experiments have shown
that NS4A and NS4B are found in membrane-associated
complexes [34]. NS4B is an integral membrane protein,
mostly localized on the cytoplasmic side of the endoplasmic
reticulum (ER) [35]. The precursor protein NS4A/B impedes
ER-to-Golgi trafﬁc, thus reducing the rate of appearance of
HLA class I on the cell surface [22]. NS4A and NS4B inhibit
cellular protein synthesis by targeting the process of trans-
lation [36], reducing immunological pressure from the
infected individual. These previously reported functions of
NS4 protein might explain our results of the effect of NS4 on
DC function.
Th1 and Th2 polarization would decide the clinical
course. Strong Th1 responses may eliminate HCV following
spontaneous resolution, but weak Th1 and strong Th2
responses may result in chronic hepatitis. The present results
show that addition of HCV recombinant proteins to iDCs
results in weakened Th1 cytokine production without
affecting Th2 production. This may explain the high chro-
nicity rate of HCV. LPS maturation recovered this Th1 defect
and may explain the immunologically competent function of
chronic hepatitis C patients.
In conclusion, our study shows that HCV proteins,
particularly NS4, affect the phenotype and function of iDCs,
but phenotype and function recover after maturation with
LPS. This is consistent with the observation that HCV is
difﬁcult to eliminate, even though HCV-infected patients
show no signs of impaired immune response.
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